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symptoms and signs of mild to moderate asthma 
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Abstract 
Background: Asthmatic patients typically show obstructive pattern on spirometry; with positive 
response to bronchodilators. However, there is paucity of data regarding presentation of obese 
patients with non-obstructive patterns of spirometry.  
Methods: A sample of 295 known asthmatic patients (74% over-weights or obese and 26% non-
obese) was selected from those attending respiratory clinic of Yastabshiron Hospital for follow up. 
A portable spirometer (All flow, Clement Clarke International, UK) was used for measurement of 
FEV1, FVC, FEV1/FVC ratio and PEF for each patient. Measurements were carried out on 
presentation and then 15 minutes following inhalation of 0.5 mg salbutamol using a spacer.  
Results: Typical obstructive pattern was found in only 17.4% of obese patients, normal pattern in 
18.3%, restrictive in 45.9% and combined pattern in 18.3%. The relation between obesity and 
patterns of spirometry was found to be statistically insignificant (P= 0.808). Significant proportions 
of all patterns showed positive reversibility tests (P= 0.000).  
Conclusion: It is concluded that all patterns of spirometry are expected in obese patients with mild 
to moderate asthma. Reversibility tests are highly significant among asthmatic patients, irrespective 
to their spirometric pattern. 
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pirometry is the recommended and the 
most widely used method for 
demonstrating airway obstruction in the 
diagnosis of asthma.1,2 Although it is widely 
used in primary health care in many countries 
worldwide;3 its use in the Sudan is almost 
restricted to outpatient departments of chest 
physicians. The most commonly used 
spirometry derived values for diagnosis of 
obstructive lung disease are the forced 
expiratory volume in one second (FEV1), the 
forced vital capacity (FVC) and the forced 
expiratory ratio (FEV1/FVC). According to 
these parameters, a spirometryreading shows 
one  of  four patterns: normal, 
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obstructive, restrictive or combined 
(obstructive/restrictive) patterns. Normal 
readings vary, depending on age, sex, body 
size, and race. A normal pattern is diagnosed 
when FEV1 & FVC are ≥ 80% of predicted 
and FEV1/FVC ratio is > 0.7. An obstructive 
pattern is diagnosed when FEV1 is less than 
80% of predicted and FEV1/FVC ratio is 0.7 
or less whereas FVC is often normal or only 
mildly reduced. With a restrictive pattern, 
both FEV1 and FVC are less than the 
predicted values whereas FEV1/FVC ratio is 
normal. All these parameters (FEV1, FVC 
and FEV1/FVC ratio) are lower than 
predicted in a combined (obstructive and 
restrictive) pattern.4,5 
Previous studies showed that the classical 
symptoms of wheezing, dyspnoea and cough 
were found in about one third of asthmatic 
patients.6 In some patients, chronic cough 
may be the sole presenting symptom.7 This 
variation in clinical presentation of asthma 
S
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may be associated with variation in patterns 
of spirometry at the time of presentation. 
On spirometry, asthma typically shows an 
obstructive pattern; however, a normal pattern 
may be detected in patients with mild asthma. 
In some patients, the only evidence of 
obstruction might be low values of Forced 
Expiratory Flow (FEF25, FEF50, FEF75 or 
FEF25-75), indicating obstruction within 
middle and small airways of the lungs. 
However, the FEF values are not as 
reproducible as FEV1.8
Because of the mechanical effect of obesity 
on the respiratory system, a restrictive pattern 
on spirometry is usually expected; however, 
there is paucity of data regarding patterns of 
spirometry among obese patients with asthma. 
The aim of this study is to determine varieties 
of spirometric patterns among obese patients 
presenting with symptoms and signs of mild 
to moderate asthma and to assess their 
responses to bronchodilators. 
 
METHODS  
This is a cross sectional study conducted in 
Yastabshiron Hospital, Khartoum-Sudan, 
during the period from November 2010 to 
May 2011. A total of 353 known asthmatic 
patients presenting with respiratory symptoms 
were examined. Results of 295 patients who 
satisfactorily completed spirometric 
measurements were accepted for analysis. 
Inclusion criteria were age 18 years or more, 
known asthmatic for at least one year, 
presenting with symptoms and signs of mild-
moderate asthma according to GINA 
classification of clinical severity1, and 
showing positive reversibility testing in 
previous records. Exclusion criteria were age 
less than 18 years, asthmatic for less than one 
year, presenting with symptoms and signs of 
severe asthma or other acute or chronic 
medical abnormality in addition to asthma, 
failure to obtain a positive reversibility testing 
in the past.  
Each asthmatic patient was asked about date 
of his asthma diagnosis, current day and night 
symptoms, frequency of asthma attacks and 
type/frequency of inhalers used in treatment. 
Clinical examination was carried out to 
exclude signs of severity and presence of 
additional medical abnormalities. A portable 
all flow spirometer (Clement Clarke 
International, UK) was used to measure FVC, 
FEV1, FEV1/FVC ratio and PEF for each 
patient. All data obtained by history taking; 
clinical examination and lung function testing 
were used for evaluation of clinical severity 
for each patient, using the GINA 
classification1.Measurements were performed 
according to the guidelines of the American 
Thoracic Society9 on presentation and then 15 
minutes following inhalation of 0.5 mg 
salbutamol using a spacer. Positive 
reversibility was accepted when FEV1 
improvement    was     greater     than 12%  or    
200  ml.5
The research conforms to the ethical 
principles of medical research developed by 
the World Medical Association Declaration of 
Helsinki.10 Written consents were obtained 
from the patients before entry into the study. 
Data obtained were analyzed using the 
Statistical Package for the Social Sciences 
version 16 (SPSS Inc. Chicago, IL, USA). 
The chi square test was used to test 
distribution of categorical variables. 
Statistical significance was accepted when P 
value was less than 0.05. 
 
RESULTS  
Male to female ratio= 1: 1.4. Ages range from 
18 to 86 years, height 144 to 188 cm, weight 
42 to 125 kg and BMI 16.1 to 46.9. Mean 
values of these parameters are presented in 
table
 
Table 1: Characteristics of Patients in the Study Group 
 
Parameter Minimum Maximum Mean (SD) 
Age 18.0 86.0 43.5 (15.3) 
Height 144.0 188.0 164.3 (9.2) 
Weight 42.0 125.0 78.2 (16.0) 
BMI 16.1 46.9 29.0 (06.0) 
Merghani TH and Alamin ME  Non-obstructive Patterns of Spirometry among Obese patients  
© Sudan JMS Vol. 7, No.3, September 2012            143
Typical obstructive pattern was found in only 
17.4% of obese patients, normal pattern in 
18.3%, restrictive in 45.9% and combined 
pattern in 18.3% (table 2). The relation 
between patterns of spirometry and obesity 
was statistically insignificant. Reversibility 
tests were positive in 14% of those with 
normal pattern, 48% of those with obstructive 
pattern, 24% of those with restrictive pattern 
and 59% of those with combined pattern. This 
finding was found to be highly statistically 
significant (table 3). 
 








Normal  17 (22.1%) 40 (18.3%) 57 (19.3%) 
Obstructive 14 (18.2%) 38 (17.4%) 52 (17.6%) 
Restrictive 35 (45.5%) 100 (45.9%) 135 (45.8%) 
Combined 11 (14.3%) 40 (18.3%) 51 (17.3%) 
Total 77 (100%) 218 (100%) 295 (100%) 
P= 0.808 
 
Table3: Reversibility Test in Relation to Patterns of Spirometry in the Study Group 
 
Reversibility test 
Pattern Negative Positive Total 
Normal 49 (86%) 8 (14%) 57 (100%) 
Obstructive 27 (51.9%) 25 (48.1%) 52 (100%) 
Restrictive 102 (75.6%) 33 (24.4%) 135 (100%) 
Combined 21 (41.2%) 30 (58.8%) 51 (100%) 




Spirometry is the most commonly used test in 
assessment of ventilatory function of the 
lungs. It detects presence of airflow 
obstruction, evaluates its severity, aids in the 
differential diagnosis of asthma, assesses 
disease progression and evaluates response to 
treatment.1-3 Abnormalities may appear even 
if the patient is asymptomatic.11In this study, 
spirometry is used for evaluation of different 
presentation patterrns expected in asthmatic 
patients. For this reason, the diagnosis of 
asthma in all patients participating in the 
study had been established, at least one year 
earlier, by a respiratory physician. To exclude 
the possibility of a wrong diagnosis, all these 
patients showed positive reversibility test in 
their records; either previously or during 
follow up. Confirmation of asthma diagnosis 
with an objective measure of lung function is 
essential. Many studies showed that history  
and clinical examination alone are not enough 
for asthma diagnosis or evaluation of its 
severity; unless augmented by lung function 
tests.12,13 
The majority of patients in the study group 
were females. This is an expected finding 
because asthma in children is more prevalent 
in boys than in girls whereas after puberty, the 
disease is more common in women.14,15 On 
the other hand, many studies reported more 
asthma symptoms16,17 and higher frequency of 
routine visits18,19 among females compared to 
males;however, few studies described sex 
difference in sensitivity to bronchodilators.20 
The major finding in this study is that, typical 
obstructive pattern was found in only 17.4% 
of obese patients, normal pattern in 18.3% 
whereas 45.9% and 18.3% showed restrictive 
and combined patterns respectively. In 
addition to that, significant proportions of all 
these patterns showed positive reversibility 
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tests. These results indicate that obese patients 
suffering from asthma may present with non-
obstructive patterns on spirometry and the 
diagnosis of asthma should not be excluded 
on a basis of that non-obstructive pattern. A 
possible explanation is that the vasodilatation 
caused by the inflammatory process within 
airways of asthmatics increases blood flow 
and makes the lungs heavier, resulting in 
reduction of FEV1 and FVC; on the other 
hand, these parameters are also reduced when 
complete obstruction within the small airways 
decreases the overall volume of air that 
ventilates the lungs, thus giving rise to 
restrictive or combined patterns. It is worth 
noting that, although obesity is a known cause 
of restrictive pattern of spirometry, only 
45.9% of obese patients showed restrictive 
pattern and on the other hand, the relation 
between patterns of spirometry and obesity 
was found to be statistically insignificant.  
When spirometric values are within normal 
range in patients with mild asthma, 
provocation tests, rather than bronchodilator 
studies are the usual next step for asthma 
diagnosis.21In this study, 19.3% of all patients 
showed normal spirometry and 14% of them 
had positive reversibility tests. This finding 
indicates that, in the symptomatic patient 
suspected of asthma, a bronchodilator study 
can be performed even if spirometry is 
normal. In addition to confirmation of asthma 
diagnosis, bronchodilator studies can relieve 
patients’ symptoms and prevent unnecessary 
aggravation of patients’ sufferings with the 
induced bronchoconstriction during the 
provocation techniques.  
 
Conclusion: 
In conclusion, our findings clearly 
demonstrate varieties of spirometric patterns 
among obese patients presenting with mild to 
moderate asthma. Significant proportions of 
all patterns showed positive reversibility tests, 
15 minutes following the bronchodilation. It 
is recommended that the diagnosis of asthma 
should not be excluded on the basis of non-
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